e-learning
resources
Stockholm 2007
Monday 17.09.2007
Childhood asthma: treatment and follow-up
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Determinants of drug prescription for respiratory symptoms in the first year of life: the WHISTLER study
B. M. de Jong, C. K. van der Ent, M. M. van der Zalm, N. Katier, T. J. M. Verheij, J. L. Kimpen, C. S. P. M. Uiterwaal (Utrecht, Netherlands)
Source:
Annual Congress 2007 - Childhood asthma: treatment and follow-up
Session:
Childhood asthma: treatment and follow-up
Session type:
Thematic Poster Session
Number:
2287
Disease area:
Paediatric lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
B. M. de Jong, C. K. van der Ent, M. M. van der Zalm, N. Katier, T. J. M. Verheij, J. L. Kimpen, C. S. P. M. Uiterwaal (Utrecht, Netherlands). Determinants of drug prescription for respiratory symptoms in the first year of life: the WHISTLER study. Eur Respir J 2007; 30: Suppl. 51, 2287
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Incidence and determinants of common respiratory symptoms in the first year of life
Source: Eur Respir J 2005; 26: Suppl. 49, 501s
Year: 2005
Day care attendance during the first year of life and occurrence of infectious respiratory morbidities and symptoms
Source: International Congress 2018 – Clinical problems in paediatric pulmonology
Year: 2018
Late Breaking Abstract - Danirixin (GSK1325756) improves respiratory symptoms and health status in mild to moderate COPD – results of a 1 year first time in patient study
Source: International Congress 2017 – Primary care management of respiratory symptoms, allergies, inhalers and adherence
Year: 2017
Acid-suppressive medications in the first year of life and risk of childhood asthma: a population-based birth cohort study
Source: Eur Respir J, 56 (5) 2000197; 10.1183/13993003.00197-2020
Year: 2020
Monitoring asthma in childhood: symptoms, exacerbations and quality of life
Source: Eur Respir Rev 2015; 24: 187-193
Year: 2015
One year dynamics of life quality depending on the adherence to therapy in patients with bronchial asthma
Source: Annual Congress 2013 –Asthma at the bedside
Year: 2013
Global asthma physician & patient (GAPP) survey: satisfaction with current asthma medications in Europe – paediatric findings
Source: Eur Respir J 2006; 28: Suppl. 50, 480s
Year: 2006
Impact of morning symptoms on 18-mo COPD outcomes across psychological distress status: a population-based study
Source: International Congress 2018 – Respiratory epidemiology: from COPD to factors that associate with lung function and infections
Year: 2018
Prevalence and risk factors of respiratory symptoms in the first year of life: a population-based cross-sectional study in the Netherlands
Source: Annual Congress 2009 - New developments in preschool wheezing disorders and its genetic basis
Year: 2009
Global asthma physician & patient (GAPP) survey: satisfaction with current asthma medications in Europe – adult findings
Source: Annual Congress 2006 - New developments in the management of asthma
Year: 2006
Follow-up after one year of an ²end of life questionnaire in chronic respiratory failure²
Source: Annual Congress 2009 - Oxygen, end-of-life and care for chronic respiratory patients
Year: 2009
Changes in prescriped inhaled COPD medication during a 3 year period in Denmark. A registry study
Source: Annual Congress 2013 –Quality of life and respiratory symptoms in primary care COPD populations
Year: 2013
Characteristics of severe asthma in China with one year follow-up: the C-BIOPRED study
Source: International Congress 2019 – Asthma and allergies worldwide
Year: 2019
Upper and lower respiratory infections in the first three years of life and doctor diagnosed asthma in adolescence. A historical birth cohort study in general practice
Source: Eur Respir J 2001; 18: Suppl. 33, 517s
Year: 2001
Patients’ adherence to treatment: How does it changes in 1 year after finishing of the participation in trial?
Source: Annual Congress 2013 –New treatments and old dilemmas in the clinical management of lung diseases
Year: 2013
Acute exacerbation of COPD- What symptoms bothers patients the most: A survey study
Source: Virtual Congress 2021 – Pulmonary rehabilitation in clinical conditions
Year: 2021
Change in respiratory symptoms and health related quality of life in a community study
Source: Annual Congress 2005 - Assessing the relevance of obstructive airway diseases
Year: 2005
Day care attendance and respiratory infectious diseases within the first 6 years of life: results from the LISA-cohort study
Source: Eur Respir J 2006; 28: Suppl. 50, 269s
Year: 2006
Risk factors associated to COPD worsening in Italian general practices: The 12 month COMODHES follow-up study
Source: International Congress 2014 – Prevalence of COPD and mortality from COPD
Year: 2014
Effect of screening for undiagnosed COPD on respiratory hospitalisation and mortality; 4 year follow up of the TargetCOPD trial
Source: International Congress 2019 – Management of airway diseases in primary care
Year: 2019
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept